Literature DB >> 23221345

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Michael K P Liu1, Natalie Hawkins, Adam J Ritchie, Vitaly V Ganusov, Victoria Whale, Simon Brackenridge, Hui Li, Jeffrey W Pavlicek, Fangping Cai, Melissa Rose-Abrahams, Florette Treurnicht, Peter Hraber, Catherine Riou, Clive Gray, Guido Ferrari, Rachel Tanner, Li-Hua Ping, Jeffrey A Anderson, Ronald Swanstrom, Myron Cohen, Salim S Abdool Karim, Barton Haynes, Persephone Borrow, Alan S Perelson, George M Shaw, Beatrice H Hahn, Carolyn Williamson, Bette T Korber, Feng Gao, Steve Self, Andrew McMichael, Nilu Goonetilleke.   

Abstract

HIV-1 accumulates mutations in and around reactive epitopes to escape recognition and killing by CD8+ T cells. Measurements of HIV-1 time to escape should therefore provide information on which parameters are most important for T cell-mediated in vivo control of HIV-1. Primary HIV-1-specific T cell responses were fully mapped in 17 individuals, and the time to virus escape, which ranged from days to years, was measured for each epitope. While higher magnitude of an individual T cell response was associated with more rapid escape, the most significant T cell measure was its relative immunodominance measured in acute infection. This identified subject-level or "vertical" immunodominance as the primary determinant of in vivo CD8+ T cell pressure in HIV-1 infection. Conversely, escape was slowed significantly by lower population variability, or entropy, of the epitope targeted. Immunodominance and epitope entropy combined to explain half of all the variability in time to escape. These data explain how CD8+ T cells can exert significant and sustained HIV-1 pressure even when escape is very slow and that within an individual, the impacts of other T cell factors on HIV-1 escape should be considered in the context of immunodominance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23221345      PMCID: PMC3533301          DOI: 10.1172/JCI65330

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  The great escape - AIDS viruses and immune control.

Authors:  P J Goulder; B D Walker
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

2.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

Authors:  W Chen; L C Antón; J R Bennink; J W Yewdell
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

3.  Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.

Authors:  Warren L Dinges; Julia Richardt; David Friedrich; Emilie Jalbert; Yi Liu; Claire E Stevens; Janine Maenza; Ann C Collier; Daniel E Geraghty; Jeremy Smith; Zoe Moodie; James I Mullins; M Juliana McElrath; Helen Horton
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.

Authors:  Dan H Barouch; Jennifer Kunstman; Marcelo J Kuroda; Jörn E Schmitz; Sampa Santra; Fred W Peyerl; Georgia R Krivulka; Kristin Beaudry; Michelle A Lifton; Darci A Gorgone; David C Montefiori; Mark G Lewis; Steven M Wolinsky; Norman L Letvin
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

5.  Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells.

Authors:  George Makedonas; Natalie Hutnick; Danielle Haney; Alexandra C Amick; Jay Gardner; Gabriela Cosma; Adam R Hersperger; Douglas Dolfi; E John Wherry; Guido Ferrari; Michael R Betts
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

Review 6.  Diversity considerations in HIV-1 vaccine selection.

Authors:  Brian Gaschen; Jesse Taylor; Karina Yusim; Brian Foley; Feng Gao; Dorothy Lang; Vladimir Novitsky; Barton Haynes; Beatrice H Hahn; Tanmoy Bhattacharya; Bette Korber
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

7.  TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.

Authors:  Huabiao Chen; Zaza M Ndhlovu; Dongfang Liu; Lindsay C Porter; Justin W Fang; Sam Darko; Mark A Brockman; Toshiyuki Miura; Zabrina L Brumme; Arne Schneidewind; Alicja Piechocka-Trocha; Kevin T Cesa; Jennifer Sela; Thai D Cung; Ildiko Toth; Florencia Pereyra; Xu G Yu; Daniel C Douek; Daniel E Kaufmann; Todd M Allen; Bruce D Walker
Journal:  Nat Immunol       Date:  2012-06-10       Impact factor: 25.606

8.  Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

Authors:  M Altfeld; E S Rosenberg; R Shankarappa; J S Mukherjee; F M Hecht; R L Eldridge; M M Addo; S H Poon; M N Phillips; G K Robbins; P E Sax; S Boswell; J O Kahn; C Brander; P J Goulder; J A Levy; J I Mullins; B D Walker
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

9.  Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.

Authors:  Rika Draenert; Sylvie Le Gall; Katja J Pfafferott; Alasdair J Leslie; Polan Chetty; Christian Brander; Edward C Holmes; Shih-Chung Chang; Margaret E Feeney; Marylyn M Addo; Lidia Ruiz; Danni Ramduth; Prakash Jeena; Marcus Altfeld; Stephanie Thomas; Yanhua Tang; Cori L Verrill; Catherine Dixon; Julia G Prado; Photini Kiepiela; Javier Martinez-Picado; Bruce D Walker; Philip J R Goulder
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

Review 10.  The immune response during acute HIV-1 infection: clues for vaccine development.

Authors:  Andrew J McMichael; Persephone Borrow; Georgia D Tomaras; Nilu Goonetilleke; Barton F Haynes
Journal:  Nat Rev Immunol       Date:  2009-12-11       Impact factor: 53.106

View more
  122 in total

Review 1.  HIV-specific CD8⁺ T cells and HIV eradication.

Authors:  R Brad Jones; Bruce D Walker
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.

Authors:  Daniel B Reeves; Christopher W Peterson; Hans-Peter Kiem; Joshua T Schiffer
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.

Authors:  Catherine Riou; Wendy A Burgers; Koleka Mlisana; Richard A Koup; Mario Roederer; Salim S Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 4.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

5.  Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV Infection.

Authors:  Victor Garcia; Marcus W Feldman
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

6.  A proposal to use iterative, small clinical trials to optimize therapeutic HIV vaccine immunogens to launch therapeutic HIV vaccine development.

Authors:  Stuart Z Shapiro
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

7.  HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths.

Authors:  Shabnum Patel; Elizabeth Chorvinsky; Shuroug Albihani; Conrad Russell Cruz; R Brad Jones; Elizabeth J Shpall; David M Margolis; Richard F Ambinder; Catherine M Bollard
Journal:  Mol Ther       Date:  2018-04-12       Impact factor: 11.454

8.  Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.

Authors:  Denis R Chopera; Roman Ntale; Nonkululeko Ndabambi; Nigel Garrett; Clive M Gray; David Matten; Quarraisha Abdool Karim; Salim Abdool Karim; Carolyn Williamson
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

Review 9.  Latency reversal and viral clearance to cure HIV-1.

Authors:  David M Margolis; J Victor Garcia; Daria J Hazuda; Barton F Haynes
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

10.  Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

Authors:  Beatrice Ondondo; Hayato Murakoshi; Genevieve Clutton; Sultan Abdul-Jawad; Edmund G-T Wee; Hiroyuki Gatanaga; Shinichi Oka; Andrew J McMichael; Masafumi Takiguchi; Bette Korber; Tomáš Hanke
Journal:  Mol Ther       Date:  2016-01-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.